Banks - Regional
Compare Stocks
2 / 10Stock Comparison
CBAN vs FISV
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
CBAN vs FISV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Banks - Regional | Information Technology Services |
| Market Cap | $371M | $30.38B |
| Revenue (TTM) | $186M | $21.09B |
| Net Income (TTM) | $28M | $3.20B |
| Gross Margin | 66.4% | 60.8% |
| Operating Margin | 18.9% | 24.4% |
| Forward P/E | 10.1x | 7.0x |
| Total Debt | $268M | $29.12B |
| Cash & Equiv. | $27M | $798M |
CBAN vs FISV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Colony Bankcorp, In… (CBAN) | 100 | 155.7 | +55.7% |
| Fiserv, Inc. (FISV) | 100 | 53.2 | -46.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CBAN vs FISV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CBAN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 4 yrs, beta 0.91, yield 2.3%
- Rev growth 5.4%, EPS growth 16.9%
- 145.0% 10Y total return vs FISV's 9.7%
FISV is the clearest fit if your priority is valuation efficiency.
- PEG 0.20 vs CBAN's 1.98
- Lower P/E (7.0x vs 10.1x), PEG 0.20 vs 1.98
- 4.0% ROA vs CBAN's 0.9%, ROIC 8.1% vs 4.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.4% NII/revenue growth vs FISV's 3.6% | |
| Value | Lower P/E (7.0x vs 10.1x), PEG 0.20 vs 1.98 | |
| Quality / Margins | 15.2% margin vs FISV's 15.2% | |
| Stability / Safety | Beta 0.91 vs FISV's 0.94, lower leverage | |
| Dividends | 2.3% yield; 4-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +32.1% vs FISV's -68.8% | |
| Efficiency (ROA) | 4.0% ROA vs CBAN's 0.9%, ROIC 8.1% vs 4.5% |
CBAN vs FISV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CBAN vs FISV — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CBAN leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
FISV is the larger business by revenue, generating $21.1B annually — 113.3x CBAN's $186M. Profitability is closely matched — net margins range from 15.2% (CBAN) to 15.2% (FISV).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $186M | $21.1B |
| EBITDAEarnings before interest/tax | $42M | $7.5B |
| Net IncomeAfter-tax profit | $28M | $3.2B |
| Free Cash FlowCash after capex | $9M | $4.0B |
| Gross MarginGross profit ÷ Revenue | +66.4% | +60.8% |
| Operating MarginEBIT ÷ Revenue | +18.9% | +24.4% |
| Net MarginNet income ÷ Revenue | +15.2% | +15.2% |
| FCF MarginFCF ÷ Revenue | -3.7% | +19.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | 0.0% | -29.1% |
Valuation Metrics
FISV leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 9.0x trailing earnings, FISV trades at a 28% valuation discount to CBAN's 12.5x P/E. Adjusting for growth (PEG ratio), FISV offers better value at 0.25x vs CBAN's 2.44x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $371M | $30.4B |
| Enterprise ValueMkt cap + debt − cash | $612M | $58.7B |
| Trailing P/EPrice ÷ TTM EPS | 12.45x | 8.96x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.08x | 7.01x |
| PEG RatioP/E ÷ EPS growth rate | 2.44x | 0.25x |
| EV / EBITDAEnterprise value multiple | 17.37x | 6.63x |
| Price / SalesMarket cap ÷ Revenue | 1.99x | 1.43x |
| Price / BookPrice ÷ Book value/share | 0.94x | 1.21x |
| Price / FCFMarket cap ÷ FCF | — | 7.00x |
Profitability & Efficiency
FISV leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
FISV delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $9 for CBAN. CBAN carries lower financial leverage with a 0.71x debt-to-equity ratio, signaling a more conservative balance sheet compared to FISV's 1.13x. On the Piotroski fundamental quality scale (0–9), CBAN scores 6/9 vs FISV's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +9.0% | +12.4% |
| ROA (TTM)Return on assets | +0.9% | +4.0% |
| ROICReturn on invested capital | +4.5% | +8.1% |
| ROCEReturn on capital employed | +1.7% | +10.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.71x | 1.13x |
| Net DebtTotal debt minus cash | $241M | $28.3B |
| Cash & Equiv.Liquid assets | $27M | $798M |
| Total DebtShort + long-term debt | $268M | $29.1B |
| Interest CoverageEBIT ÷ Interest expense | 0.63x | 6.39x |
Total Returns (Dividends Reinvested)
CBAN leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CBAN five years ago would be worth $13,521 today (with dividends reinvested), compared to $4,829 for FISV. Over the past 12 months, CBAN leads with a +32.1% total return vs FISV's -68.8%. The 3-year compound annual growth rate (CAGR) favors CBAN at 33.7% vs FISV's -22.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +13.2% | -13.4% |
| 1-Year ReturnPast 12 months | +32.1% | -68.8% |
| 3-Year ReturnCumulative with dividends | +138.8% | -52.5% |
| 5-Year ReturnCumulative with dividends | +35.2% | -51.7% |
| 10-Year ReturnCumulative with dividends | +145.0% | +9.7% |
| CAGR (3Y)Annualised 3-year return | +33.7% | -22.0% |
Risk & Volatility
CBAN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CBAN is the less volatile stock with a 0.91 beta — it tends to amplify market swings less than FISV's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBAN currently trades 91.6% from its 52-week high vs FISV's 29.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.91x | 0.94x |
| 52-Week HighHighest price in past year | $21.61 | $191.91 |
| 52-Week LowLowest price in past year | $14.63 | $52.91 |
| % of 52W HighCurrent price vs 52-week peak | +91.6% | +29.6% |
| RSI (14)Momentum oscillator 0–100 | 43.4 | 36.5 |
| Avg Volume (50D)Average daily shares traded | 258K | 5.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates CBAN as "Hold" and FISV as "Buy". CBAN is the only dividend payer here at 2.28% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | — | $74.64 |
| # AnalystsCovering analysts | 2 | 60 |
| Dividend YieldAnnual dividend ÷ price | +2.3% | — |
| Dividend StreakConsecutive years of raises | 4 | — |
| Dividend / ShareAnnual DPS | $0.45 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +19.4% |
CBAN leads in 3 of 6 categories (Income & Cash Flow, Total Returns). FISV leads in 2 (Valuation Metrics, Profitability & Efficiency).
CBAN vs FISV: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CBAN or FISV a better buy right now?
For growth investors, Colony Bankcorp, Inc.
(CBAN) is the stronger pick with 5. 4% revenue growth year-over-year, versus 3. 6% for Fiserv, Inc. (FISV). Fiserv, Inc. (FISV) offers the better valuation at 9. 0x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate Fiserv, Inc. (FISV) a "Buy" — based on 60 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CBAN or FISV?
On trailing P/E, Fiserv, Inc.
(FISV) is the cheapest at 9. 0x versus Colony Bankcorp, Inc. at 12. 5x. On forward P/E, Fiserv, Inc. is actually cheaper at 7. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Fiserv, Inc. wins at 0. 20x versus Colony Bankcorp, Inc. 's 1. 98x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CBAN or FISV?
Over the past 5 years, Colony Bankcorp, Inc.
(CBAN) delivered a total return of +35. 2%, compared to -51. 7% for Fiserv, Inc. (FISV). Over 10 years, the gap is even starker: CBAN returned +145. 0% versus FISV's +9. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CBAN or FISV?
By beta (market sensitivity over 5 years), Colony Bankcorp, Inc.
(CBAN) is the lower-risk stock at 0. 91β versus Fiserv, Inc. 's 0. 94β — meaning FISV is approximately 4% more volatile than CBAN relative to the S&P 500. On balance sheet safety, Colony Bankcorp, Inc. (CBAN) carries a lower debt/equity ratio of 71% versus 113% for Fiserv, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CBAN or FISV?
By revenue growth (latest reported year), Colony Bankcorp, Inc.
(CBAN) is pulling ahead at 5. 4% versus 3. 6% for Fiserv, Inc. (FISV). On earnings-per-share growth, the picture is similar: Fiserv, Inc. grew EPS 17. 8% year-over-year, compared to 16. 9% for Colony Bankcorp, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CBAN or FISV?
Fiserv, Inc.
(FISV) is the more profitable company, earning 16. 4% net margin versus 15. 2% for Colony Bankcorp, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FISV leads at 26. 9% versus 18. 9% for CBAN. At the gross margin level — before operating expenses — CBAN leads at 66. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CBAN or FISV more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Fiserv, Inc. (FISV) is the more undervalued stock at a PEG of 0. 20x versus Colony Bankcorp, Inc. 's 1. 98x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Fiserv, Inc. (FISV) trades at 7. 0x forward P/E versus 10. 1x for Colony Bankcorp, Inc. — 3. 1x cheaper on a one-year earnings basis.
08Which pays a better dividend — CBAN or FISV?
In this comparison, CBAN (2.
3% yield) pays a dividend. FISV does not pay a meaningful dividend and should not be held primarily for income.
09Is CBAN or FISV better for a retirement portfolio?
For long-horizon retirement investors, Colony Bankcorp, Inc.
(CBAN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 91), 2. 3% yield, +145. 0% 10Y return). Both have compounded well over 10 years (CBAN: +145. 0%, FISV: +9. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CBAN and FISV?
These companies operate in different sectors (CBAN (Financial Services) and FISV (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
CBAN pays a dividend while FISV does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.